VIMA THERAPEUTICS
Live / Applied — Third extension granted (statement of use) (as of 08 Jan 2026)
What this means for you
Not registered yet, but its 06 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98166904
- Mark type
- Stylized text
- Filed
- 06 Sept 2023
- Published for opposition
- 04 Jun 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical preparations for the treatment of movement disorders, dystonia, Huntington's disease, and Parkinson's disease
- Class 042 — Scientific and technological services: Research and development in the field of neuroscience; providing scientific research information in the fields of neuroscience, therapeutics to treat movement disorders, and clinical trials for the same
Owner
- Vima Therapeutics, Inc., Cambridge, MA, US
- Vima Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 09 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2026 — SOU EXTENSION 3 GRANTED
- 08 Jan 2026 — SOU EXTENSION 3 FILED
- 08 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2025 — SOU EXTENSION 2 GRANTED
- 15 Jul 2025 — SOU EXTENSION 2 FILED
- 15 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2025 — SOU EXTENSION 1 GRANTED
- 08 Jan 2025 — SOU EXTENSION 1 FILED
- 08 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2024 — PUBLISHED FOR OPPOSITION